Table 2.
Data collection schedule and measures
| Measure | Time 1 All women (routinely collected data) |
Time 2 Consenting women only |
Time 3 Health professionals only |
|---|---|---|---|
| Demographic informationa | X | ||
| EPDSa | X | X | |
| Psychosocial assessmenta | X | ||
| Routine referral informationb,c | X | ||
| Feedback survey (women)d | X | ||
| Costing data | X | X | |
| Feedback survey; observational data; key informant interviews; focus groups (health professionals)b,c,e | X | ||
| Whooley questionsf | X | ||
| GAD-2f,g | X | ||
| MGMQf,g | X | ||
| MINIf,g | X | ||
| Interval questionf,g | X | ||
| Brief help seeking itemsf,g | X |
EPDS Edinburgh Perinatal Depression Scale, GAD-2 Generalized Anxiety Disorder Scale-2items, MGMQ Matthey Generic Mood Questionnaire, MINI Mini International Neuropsychiatric Interview (v6.0; mood and anxiety disorder modules only; Data will be used to address: aAll aims; bPrimary Aim 1 (clinical effectiveness); cPrimary Aim 2 (cost effectiveness); dPrimary Aim 3 (pregnant women perspectives); ePrimary Aim 3 (health care provider perspectives); fSecondary Aim (psychometric evaluation). gCompleted by women allocated to the PIPA model of care only